Explain this page
Arphra AIPlain-English read on Insmed Incorporated’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for INSM.
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.71% | -4.51% | -22.71% | -29.94% | -50.19% | -40.82% | +40.93% | +428.97% | +309.18% | +763.29% | -37.58% |
Aftermarket
LiveLast trade
$102.99
100 sh
Bid
$95.75
306 sh
Ask
$111.15
2 sh
Spread
$15.400
Sector & industry today
LiveSectors
- Healthcare+1.76%
- Financial Services+1.27%
- Industrials+1.02%
- Real Estate+0.90%
- Energy+0.80%
- Consumer Defensive+0.59%
- Consumer Cyclical+0.53%
- Basic Materials+0.19%
- Utilities-1.16%
- Technology-1.74%
- Communication Services-2.12%
Top industries (issuer's industry highlighted)
- Biotechnology-1.36%
- Investment - Banking & Investment Services-5.20%
- Rental & Leasing Services+4.71%
- Software - Application-3.78%
- Broadcasting-3.48%
- Auto - Recreational Vehicles+3.46%
- Financial - Mortgages-3.40%
- Internet Content & Information-2.83%
- Software - Infrastructure-2.80%
- Apparel - Retail+2.77%
- Department Stores+2.59%
- Solar-2.55%
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $213.11 (+107.35%)
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Insmed Incorporated (INSM) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Insmed Reports First-Quarter 2026 Financial Results and Provides Business Updateprnewswire.com·May 07, 2026
- Insmed and Ty Pennington Team Up to Drive Awareness and Proper Diagnosis of Bronchiectasisprnewswire.com·May 06, 2026
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026prnewswire.com·May 04, 2026
- Insmed to Present Data Across Its Respiratory Portfolio, Including Late-Breaking ARIKAYCE® Results from Phase 3b ENCORE Study, at the American Thoracic Society International Conference 2026prnewswire.com·May 04, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|